Literature DB >> 9632703

Chicken ovalbumin upstream promoter-transcription factor (COUP-TF) modulates expression of the Purkinje cell protein-2 gene. A potential role for COUP-TF in repressing premature thyroid hormone action in the developing brain.

G W Anderson1, R J Larson, D R Oas, C R Sandhofer, H L Schwartz, C N Mariash, J H Oppenheimer.   

Abstract

The cerebellar Purkinje cell-specific PCP-2 gene is transcriptionally activated by thyroid hormone during the 2nd and 3rd weeks of postnatal life in the rat. In contrast, thyroid hormone has no detectable effects on PCP-2 expression in the fetal rat. We now present data that suggest that the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor (COUP-TF) represses triiodothyronine (T3)-dependent transcriptional activation of PCP-2 in the immature Purkinje cell. Gel shift assays show that the PCP-2 A1TRE and adjoining sequences (-295/-199 region) bind to rat and mouse brain nucleoproteins in a developmentally regulated fashion and that one of these nucleoproteins could be the orphan nucleoprotein COUP-TF. In support of this hypothesis, in vitro translated COUP-TF binds to the -295/-199 region and COUP-TF represses T3-dependent activation of the PCP-2 promoter in transient transfection analyses. Finally, immunohistochemical studies reveal that COUP-TF is specifically expressed in the immature fetal and early neonatal Purkinje cell and that this expression diminishes coincident with thyroid hormone induction of PCP-2 expression. Our findings are consistent with the hypothesis that the presence or absence of inhibitory proteins bound to the thyroid hormone response element of T3-responsive genes governs the responsivity of these genes to thyroid hormone during brain development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632703     DOI: 10.1074/jbc.273.26.16391

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Tissue-specific actions of thyroid hormone: insights from animal models.

Authors:  G A Brent
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 2.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

3.  Differential expression of COUP-TFI, CHL1, and two novel genes in developing neocortex identified by differential display PCR.

Authors:  Q Liu; N D Dwyer; D D O'Leary
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 4.  An overview of nuclear receptor coregulators involved in cerebellar development.

Authors:  Eijun Nishihara
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 5.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Thyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression.

Authors:  Yan-Yun Liu; Teruyo Nakatani; Takahiko Kogai; Kaizeen Mody; Gregory A Brent
Journal:  Endocrinology       Date:  2011-01-25       Impact factor: 4.736

7.  Perinatal copper deficiency alters rat cerebellar purkinje cell size and distribution.

Authors:  Jacob A Lyons; Joseph R Prohaska
Journal:  Cerebellum       Date:  2010-03       Impact factor: 3.847

Review 8.  Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2018-02-09       Impact factor: 12.310

Review 9.  Current perspectives on the role of thyroid hormone in growth and development of cerebellum.

Authors:  Noriyuki Koibuchi; Hisaka Jingu; Toshiharu Iwasaki; William W Chin
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

10.  Nuclear receptor complement of the cnidarian Nematostella vectensis: phylogenetic relationships and developmental expression patterns.

Authors:  Adam M Reitzel; Ann M Tarrant
Journal:  BMC Evol Biol       Date:  2009-09-10       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.